Tissue engineering has brought revolutionary potential to the regenerative repair of damaged tissues, providing innovative solutions to restore function.

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...

BioLamina CEO Klaus Langhoff-Roos discusses the challenges of scaling stem cell production from lab plates to bioreactors, ...

New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative ...

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under two years, despite ...

BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...

Utrecht University, University Medical Center Utrecht, and Princess Máxima Center have each been awarded a Vidi grant worth up to €850,000.

I went into cancer care and cancer research because, when I was a fellow, it was the medical specialty with the largest ...

IND application filed for MP0712, the Company’s lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images ...

The proposed dual listing on both NASDAQ and HKEX is a key element of our global growth strategy ... activates T cells via the 4-1BB signaling pathway in the tumor microenvironment where Claudin 18.2 ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer immunotherapy, yet their efficacy varies widely across individuals. Emerging evidence ...